MDMA is a stimulant and entactogen often associated with parties, clubs, and festivals. For many people, use starts as “social” and then escalates through a repeating pattern:

• Normal functioning during the week
• Weekend use
• Emotional or physical crash
• “It was just this one time”
• Repeat

At first, the problem may not look like “addiction.” It often looks like:

• “I need it to go out”
• “I cannot enjoy myself without it”
• “Afterwards I feel depressed or anxious”
• “I need more now – or I mix it so it hits harder”

In real life, “Molly” and “ecstasy” do not always mean purity or consistent content. That complicates everything – effects, risk, and recovery.

What matters most for treatment decisions:

• Uncertain content (pills or powder that may be mixed)
• Potency variability
• Common polysubstance use (alcohol, cannabis, stimulants, benzodiazepines)

That is why we avoid assumptions. We start with assessment and a plan based on what is actually happening.

Many families reach out because of “the after”:

• Intense anxiety
• Insomnia or severely disrupted sleep
• Low mood (sadness, irritability, emptiness)
• Cravings and urgency to use again
• Impulsivity and risky decisions

When the cycle repeats, the problem stops being the party. The problem becomes that daily life starts revolving around use and the crash.

Signs vary. Not all signs must be present for the situation to be serious.

Behavioral signs

• Weekends centered on partying and recovery
• Secrecy about plans, money, or going out
• Loss of interest in normal activities
• Lying or minimizing (“it is not that much”, “everyone does it”)
• Mixing substances to control the effect (up, down, or sleep)

Physical signs

• Disrupted sleep (days of instability)
• Extreme fatigue and low energy during the week
• Appetite changes
• Jaw tension or bruxism (in some cases)

Emotional and mental signs

• Anxiety or panic attacks
• Depression or irritability after use
• Paranoia or suspicious thinking (in some cases)
• Emotional dysregulation (highs and lows)

We do not need alarmism to be clear. With MDMA – Molly, risks often concentrate in:

• High-risk decisions due to impulsivity and party environments
• Mental health symptoms (anxiety, depression, panic)
• Polysubstance use and unpredictable reactions
• Safety concerns when dehydration, heat, sleep loss, or mixing substances are involved

The clinical point is not to scare. It is to assess risk level, define supervision needs, and build a realistic plan.

Detox is not the full treatment. With MDMA – Molly, we often focus more on stabilization than “detox” in the classic sense.

Stabilization may focus on:

• Safety and clinical observation
• Restoring sleep and routine
• Monitoring anxiety, mood, and impulsivity
• Evaluating mental health symptoms
• Connecting stabilization to residential treatment to reduce relapse risk

Our intake follows a clear clinical sequence:

• Nursing intake assessment
• Belongings safety check (restricted items are returned to family or secured)
• Medical evaluation within 24 hours
• Psychiatric evaluation within 72 hours (sooner if needed)
• 24/7 nursing as the first line of observation

If a higher level of medical care is needed, we coordinate transfer and accompaniment and keep the family informed.

A residential program for MDMA – Molly is not just “stop going out.” The real goal is sustained abstinence, restored functioning, and lower relapse risk.

1) Assessment first

We define profile, risks, recent use, polysubstance use, and mental health. Without assessment, plans often fail.

2) Residential structure to break the cycle

In a private residential environment, we work on:

• Daily routine to stabilize sleep and habits
• Clinical supervision based on the case
• Therapeutic support for cravings, social pressure, and triggers

3) Relapse prevention with practical tools

Relapse prevention is built through skills:

• Triggers – friends – places – music – events
• A plan for the crash and anxiety
• Decisions and boundaries in social settings
• Routines that support energy and mood

4) Family work

For U.S. families, loved ones often coordinate decisions. We provide guidance on communication and boundaries, especially when the person resists help.

With MDMA – Molly, polysubstance use is common. During admissions, we review the case carefully when there is:

• MDMA – Molly and alcohol
• MDMA – Molly and cannabis
• MDMA – Molly and stimulants
• MDMA – Molly and benzodiazepines
• Anxiety, depression, trauma, or other symptoms alongside use

A dual diagnosis plan can change treatment intensity, supervision needs, and recommended length of stay.

For U.S. families, Lima can be a strong option when you need:

• Privacy
• Distance from triggers (friends, events, access)
• Daily structure that breaks the pattern
• Clear steps to coordinate from the U.S.

The goal is not travel for travel’s sake. The goal is to create real conditions for recovery to begin.

If the person is already in Peru, we can often move faster.

• Same-day admissions call
• Intake checklist (documents and medications)
• Coordination to arrive in Lima if the person is outside the city

To avoid delays, we typically ask you to prepare:

• A valid passport
• Current prescription medication information if applicable
• Prior medical or mental health records if available

During the admissions call, we confirm the exact checklist based on age, medical profile, and the needs of the case.